In brief they showed that among HIV-infected adults on ART with a CD4 count above 250 cells/mm3, discontinuing CTX significantly increased the risk of CTX preventable bacterial infections (particularly pneumonia), and of malaria and led to an increase in hospital admission rates. The gene discussed is CD4; the disease is malaria.